Physician profile
Peter John Carter
NPI 1366768640
$1,373.22
in general payments reported to CMS, 2019-2025
20 companies · $159 in 2025
The $159 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $116 · 2021: $261 · 2022: $208 · 2023: $213 · 2024: $146 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $236.50 | 2019-2024 | |
| Supernus Pharmaceuticals, INC. | $192.79 | 2022-2025 | Qelbree |
| Cranial Technologies, INC | $189.29 | 2019-2024 | Doc Band |
| Tris Pharma INC | $144.98 | 2019-2022 | |
| Neos Therapeutics, LP | $86.81 | 2021-2023 | Cotempla Xr-Odt |
| Corium, LLC | $81.91 | 2022-2023 | Azstarys |
| Ironshore Pharmaceuticals INC. | $76.45 | 2019-2022 | |
| Sobi, INC | $69.85 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.07 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $35.45 | 2025 | Jornay Pm |
| Shire North American Group INC | $31.51 | 2019 | |
| Sanofi-Aventis U.S. LLC | $29.52 | 2025 | |
| Sanofi Pasteur INC. | $28.74 | 2021 | |
| Arbor Pharmaceuticals, INC. | $21.05 | 2019 | |
| Seqirus USA INC | $19.96 | 2025 | Flucelvax |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $19.19 | 2024 | |
| Rhodes Pharmaceuticals L.P. | $15.45 | 2019 | |
| Taiho Oncology, INC. | $14.64 | 2025 | |
| Merck Sharp & Dohme LLC | $14.29 | 2019 | |
| Abbott Laboratories | $11.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.